Biological agents in kidney transplantation: belatacept is entering the field.
Wéclawiak, Hugo
Biological agents in kidney transplantation: belatacept is entering the field. [electronic resource] - Expert opinion on biological therapy Oct 2010 - 1501-8 p. digital
Publication Type: Journal Article; Review
1744-7682
10.1517/14712598.2010.514901 doi
Abatacept
Animals
Calcineurin Inhibitors
Drug Therapy, Combination
Graft Rejection--immunology
Graft Survival--drug effects
Humans
Immunoconjugates--adverse effects
Immunosuppressive Agents--adverse effects
Kidney Transplantation--immunology
Sirolimus--therapeutic use
Time Factors
Transplantation, Homologous
Treatment Outcome
Biological agents in kidney transplantation: belatacept is entering the field. [electronic resource] - Expert opinion on biological therapy Oct 2010 - 1501-8 p. digital
Publication Type: Journal Article; Review
1744-7682
10.1517/14712598.2010.514901 doi
Abatacept
Animals
Calcineurin Inhibitors
Drug Therapy, Combination
Graft Rejection--immunology
Graft Survival--drug effects
Humans
Immunoconjugates--adverse effects
Immunosuppressive Agents--adverse effects
Kidney Transplantation--immunology
Sirolimus--therapeutic use
Time Factors
Transplantation, Homologous
Treatment Outcome